Suspended, active non-recruiting and recruiting oncological phase 1, 2, 3 clinical trials respectively throughout the world from the beginning of pandemic to the first six months of 2022 (30/01/2020 to 30/06/2022)
| Study status | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|
| Suspended | 33 | 41 | 5 |
| Active, non-recruiting | 236 | 357 | 118 |
| Recruiting | 2,368 | 3,474 | 818 |
| Total | 3,592 | 5,466 | 1,464 |